company background image
300653 logo

Yantai Zhenghai Biotechnology SZSE:300653 Stock Report

Last Price

CN¥20.14

Market Cap

CN¥3.6b

7D

-0.6%

1Y

-17.5%

Updated

23 Jan, 2025

Data

Company Financials +

Yantai Zhenghai Biotechnology Co., Ltd.

SZSE:300653 Stock Report

Market Cap: CN¥3.6b

300653 Stock Overview

Engages in the research and development, production, and marketing of regenerative medical materials in China. More details

300653 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Rewards

Price-To-Earnings ratio (21.4x) is below the CN market (34.6x)

Earnings are forecast to grow 15.03% per year

Risk Analysis

Unstable dividend track record


My Notes

Capture your thoughts, links and company narrative

Yantai Zhenghai Biotechnology Co., Ltd. Competitors

Medicalsystem Biotechnology

SZSE:300439

CN¥3.9b

Getein Biotech

SHSE:603387

CN¥4.0b

Beijing Kawin Technology Share-Holding

SHSE:688687

CN¥3.8b

Shanghai OPM Biosciences

SHSE:688293

CN¥4.5b

Price History & Performance

Summary of share price highs, lows and changes for Yantai Zhenghai Biotechnology
Historical stock prices
Current Share PriceCN¥20.14
52 Week HighCN¥28.57
52 Week LowCN¥17.65
Beta0.38
1 Month Change-8.62%
3 Month Change-12.21%
1 Year Change-17.49%
3 Year Change-48.77%
5 Year Change-41.32%
Change since IPO168.45%

Recent News & Updates

Recent updates

Yantai Zhenghai Biotechnology Co., Ltd.'s (SZSE:300653) Shares Not Telling The Full Story

Sep 28
Yantai Zhenghai Biotechnology Co., Ltd.'s (SZSE:300653) Shares Not Telling The Full Story

Yantai Zhenghai Biotechnology Co., Ltd. (SZSE:300653) Held Back By Insufficient Growth Even After Shares Climb 26%

Mar 04
Yantai Zhenghai Biotechnology Co., Ltd. (SZSE:300653) Held Back By Insufficient Growth Even After Shares Climb 26%

Shareholder Returns

300653CN BiotechsCN Market
7D-0.6%0.7%0.6%
1Y-17.5%-13.8%12.8%

Return vs Industry: 300653 underperformed the CN Biotechs industry which returned -13.8% over the past year.

Return vs Market: 300653 underperformed the CN Market which returned 12.8% over the past year.

Price Volatility

Is 300653's price volatile compared to industry and market?
300653 volatility
300653 Average Weekly Movement4.4%
Biotechs Industry Average Movement5.6%
Market Average Movement6.9%
10% most volatile stocks in CN Market10.9%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 300653 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300653's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003354Kan Songwww.zhbio.com

Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and marketing of regenerative medical materials in China. The company offers oral repair membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, and self-etching adhesives. It products are used in various fields, such as dentistry, head and neck surgery, neurosurgery, and otolaryngology.

Yantai Zhenghai Biotechnology Co., Ltd. Fundamentals Summary

How do Yantai Zhenghai Biotechnology's earnings and revenue compare to its market cap?
300653 fundamental statistics
Market capCN¥3.61b
Earnings (TTM)CN¥167.68m
Revenue (TTM)CN¥383.22m

21.4x

P/E Ratio

9.4x

P/S Ratio

Is 300653 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300653 income statement (TTM)
RevenueCN¥383.22m
Cost of RevenueCN¥48.16m
Gross ProfitCN¥335.06m
Other ExpensesCN¥167.38m
EarningsCN¥167.68m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Apr 15, 2025

Earnings per share (EPS)0.94
Gross Margin87.43%
Net Profit Margin43.76%
Debt/Equity Ratio0%

How did 300653 perform over the long term?

See historical performance and comparison

Dividends

4.0%

Current Dividend Yield

86%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 09:36
End of Day Share Price 2025/01/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yantai Zhenghai Biotechnology Co., Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yanyin ZhuChina International Capital Corporation Limited
Bin WuChina Merchants Securities Co. Ltd.
Wen DaiHuatai Research